Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | PROTEASOME | authKW | 999160 | 10% | 31% | 1400 |
2 | UBIQUITIN | authKW | 861186 | 10% | 29% | 1322 |
3 | SUMO | authKW | 469680 | 3% | 57% | 360 |
4 | SUMOYLATION | authKW | 327823 | 2% | 46% | 310 |
5 | PROTEASOME INHIBITOR | authKW | 284971 | 3% | 36% | 350 |
6 | IMMUNOPROTEASOME | authKW | 227982 | 1% | 74% | 136 |
7 | NEDD8 | authKW | 222597 | 1% | 81% | 121 |
8 | BORTEZOMIB | authKW | 171771 | 3% | 21% | 363 |
9 | 20S PROTEASOME | authKW | 165197 | 1% | 66% | 110 |
10 | UBC9 | authKW | 162158 | 1% | 66% | 108 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 49356 | 50% | 0% | 6859 |
2 | Cell Biology | 38825 | 28% | 1% | 3870 |
3 | Biophysics | 6172 | 9% | 0% | 1185 |
4 | Oncology | 6001 | 13% | 0% | 1757 |
5 | Genetics & Heredity | 1499 | 6% | 0% | 795 |
6 | Biochemical Research Methods | 816 | 4% | 0% | 488 |
7 | Developmental Biology | 592 | 2% | 0% | 233 |
8 | Pathology | 485 | 2% | 0% | 325 |
9 | Chemistry, Medicinal | 341 | 2% | 0% | 314 |
10 | Hematology | 270 | 2% | 0% | 303 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PROT METAB | 29321 | 0% | 26% | 50 |
2 | BIOTECHNOL THURGAU | 26557 | 0% | 45% | 26 |
3 | BIOMOL STRUCT ORG | 23544 | 0% | 27% | 39 |
4 | CELL BIOL METAB GRP | 20281 | 0% | 68% | 13 |
5 | PROT PROC SECT | 19005 | 0% | 83% | 10 |
6 | DEGENERAT NEUROL DIS | 18483 | 0% | 18% | 44 |
7 | NEW FRONTIER SCI | 17183 | 0% | 54% | 14 |
8 | CLIN PHYS MED | 15953 | 0% | 50% | 14 |
9 | ACUTE LUNG INJURY EXCELLENCE | 15690 | 0% | 33% | 21 |
10 | BIOCHEM CCM | 15392 | 0% | 75% | 9 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MOLECULAR CELL | 20244 | 2% | 4% | 226 |
2 | JOURNAL OF BIOLOGICAL CHEMISTRY | 14479 | 7% | 1% | 1029 |
3 | ENZYME & PROTEIN | 7297 | 0% | 19% | 17 |
4 | CELL DIVISION | 6274 | 0% | 12% | 24 |
5 | NATURE STRUCTURAL & MOLECULAR BIOLOGY | 5179 | 1% | 3% | 72 |
6 | EMBO REPORTS | 4685 | 0% | 3% | 69 |
7 | EMBO JOURNAL | 4648 | 1% | 1% | 194 |
8 | MOLECULAR & CELLULAR PROTEOMICS | 3861 | 1% | 2% | 75 |
9 | FEBS LETTERS | 3572 | 2% | 1% | 268 |
10 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 3497 | 3% | 1% | 350 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PROTEASOME | 999160 | 10% | 31% | 1400 | Search PROTEASOME | Search PROTEASOME |
2 | UBIQUITIN | 861186 | 10% | 29% | 1322 | Search UBIQUITIN | Search UBIQUITIN |
3 | SUMO | 469680 | 3% | 57% | 360 | Search SUMO | Search SUMO |
4 | SUMOYLATION | 327823 | 2% | 46% | 310 | Search SUMOYLATION | Search SUMOYLATION |
5 | PROTEASOME INHIBITOR | 284971 | 3% | 36% | 350 | Search PROTEASOME+INHIBITOR | Search PROTEASOME+INHIBITOR |
6 | IMMUNOPROTEASOME | 227982 | 1% | 74% | 136 | Search IMMUNOPROTEASOME | Search IMMUNOPROTEASOME |
7 | NEDD8 | 222597 | 1% | 81% | 121 | Search NEDD8 | Search NEDD8 |
8 | BORTEZOMIB | 171771 | 3% | 21% | 363 | Search BORTEZOMIB | Search BORTEZOMIB |
9 | 20S PROTEASOME | 165197 | 1% | 66% | 110 | Search 20S+PROTEASOME | Search 20S+PROTEASOME |
10 | UBC9 | 162158 | 1% | 66% | 108 | Search UBC9 | Search UBC9 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |